7 results
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff Guidelines ... Potential Treatment ... infection Episode #Pharmacology ... #Management #CDiff ... IDSA2017 #Adjunct #Antibiotics
IDSA Treatment of Necrotizing Infections of the Skin, Fascia, and Muscle
 • Mixed infections
 • Streptococcus
IDSA Treatment of ... Staphylococcus aureus • Clostridium ... fasciitis #Skin #IDSA #Treatment ... #management #antibiotics ... #pharmacology
Antibiotic treatment durations for first line antibiotics recommended by Public Health England (PHE) guidance
 • Acute
Antibiotic treatment ... exacerbation of COPD ... #management #durations ... primarycare #outpatient #treatment ... #pharmacology #
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... Acquired #Pneumonia #Antibiotics ... #Treatment #Regimen ... #Management #Guidelines ... #pharmacology
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... indicate preferred treatment ... #Management #Pulmonary ... #COPD #GOLD2017 ... LAMA #LABA #ICS #Guidelines
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
pulmonary disease (COPD ... corticosteroids, antibiotics ... #COPD #Treatment ... #Algorithm #Management ... SABA #SAMA #ICS #Pharmacology
Guidelines on Management of Clostridioides difficile Infection (CDI) in Adults
 • Non-Severe CDI
 • Severe CDI
Guidelines on Management ... @DharSaty #Clostridium ... difficile #CDiff #CDI #management ... #pharmacology # ... treatment